RICHARD HIGHTOWER: Open Payments
NPI 1487652285 · POOLER, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,966 in 119 payments from 24 companies in 2025. Trend: 2023 $2,472 · 2024 $2,502 · 2025 $1,966
Food & beverage: $1,966
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $254 |
| PFIZER INC. | 15 | $241 |
| ABBVIE INC. | 12 | $202 |
| Lilly USA, LLC | 11 | $161 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Astellas Pharma US Inc | 6 | $122 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Otsuka America Pharmaceutical, Inc. | 4 | $91 |
| Dexcom, Inc. | 5 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $65 |
Products named: ELIQUIS, MOUNJARO, QULIPTA, Veozah, REXULTI, Wegovy, FARXIGA, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
